Micro-Tech News

Here's What's Concerning About Micro-Tech (Nanjing)Ltd's (SHSE:688029) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and al

Simply Wall St22:51 ET

Micro-tech (688029.SH) will distribute RMB 10 yuan for every 10 shares in 2023, with the share registration day on June 21.

Nanwei Medical (688029.SH) announced that it will distribute an annual equity dividend in 2023, with a cash dividend of 10 yuan (including tax) for every 10 shares. The record date for shareholders is June 21.

Zhitong FinanceJun 17 05:41 ET

Is Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Recent Stock Performance Tethered To Its Strong Fundamentals?

Micro-Tech (Nanjing)Ltd's (SHSE:688029) stock is up by a considerable 14% over the past month. Given the company's impressive performance, we decided to study its financial indicators more closely a

Simply Wall StMay 21 19:54 ET

Nanwei Medical (688029.SH): Appoints Li Changqing as the company's executive president

Gelonghui, May 20 | Nanwei Medical (688029.SH) announced that the board of directors agreed to appoint Mr. CHANGQING LI (Li Changqing) as the company's executive president. His role is to assist the president to preside over the overall production and operation management of the company in accordance with the president's authorization. The term of office starts from the date of review and approval by the board of directors and ends on the date the term of the third board of directors expires.

Gelonghui FinanceMay 20 04:14 ET

Huakang Limited, the major shareholder of Nanwei Medical (688029.SH), reduced its holdings by 1.04%

Southern Weimedicine (688029.SH) Notice, May 15, 2024 to May 17, 2024, Public...

Zhitong FinanceMay 17 09:41 ET

Nanwei Medical (688029.SH) released 2023 annual results, with net profit of 486 million yuan, an increase of 46.99% over the previous year

Nanwei Medical (688029.SH) released its 2023 annual report. The company achieved operating income of 24 during the reporting period...

Zhitong FinanceApr 25 07:59 ET

Nanwei Medical (688029.SH): Shareholder Huakang Limited plans to reduce its total holdings by no more than 1.99%

On April 18, Ge Longhui Medical (688029.SH) announced that due to its own capital requirements, Huakang Limited plans to reduce the total holdings of the company's shares by no more than 3,738,163 shares through centralized bidding and bulk transactions through the Shanghai Stock Exchange trading system. Of these, those planning to reduce their holdings through centralized bidding transactions on the stock exchange will reduce their holdings by no more than 1,878,474 shares within 90 days (May 15 to August 12, 2024) after the disclosure of the shareholding reduction plan announcement. and any 90 consecutive times

Gelonghui FinanceApr 18 07:57 ET

There's No Escaping Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Muted Earnings

When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 28x, you may consider Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) as an attractive investment with its 24.9x P

Simply Wall StApr 17 23:21 ET

Nanwei Medical (688029.SH): A total cost of 29.99 million yuan to buy back 0.23% of the shares

Gelonghui, April 1, 丨 Nanwei Medicine (688029.SH) announced that as of March 31, 2024, the company had repurchased a total of 432,344 shares through the Shanghai Stock Exchange trading system, accounting for 0.23% of the company's total share capital. The highest repurchase transaction price was 71.70 yuan/share, the lowest price was 67.91 yuan/share, and the total amount of capital paid was RMB 29,992,449 (excluding transaction fees such as stamp duty and transaction fees).

Gelonghui FinanceApr 1 08:34 ET

These 4 Measures Indicate That Micro-Tech (Nanjing)Ltd (SHSE:688029) Is Using Debt Safely

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor

Simply Wall StMar 19 19:04 ET

Nanwei Medicine (688029.SH): Zhongke Investment Holdings Reduction Plan by 498,500 Shares Expires

On March 4, Ge Longhui Medical (688029.SH) announced that on March 1, 2024, the company received a notification letter from Zhongke Investment. As of March 1, 2024, the period of this holdings reduction plan has expired, and Zhongke Investment has reduced its holdings by 498,500 shares through centralized bidding transactions.

Gelonghui FinanceMar 4 06:52 ET

Nanwei Medical (688029.SH): A total of 257,300 shares have been repurchased

Gelonghui, March 4, 丨 Nanwei Medicine (688029.SH) announced that as of February 29, 2024, the company had repurchased 257,317 shares of the company's shares through centralized bidding transactions, accounting for 0.14% of the company's total share capital. The highest repurchase transaction price was 71.70 yuan/share, the lowest price was 67.91 yuan/share, and the total capital paid was RMB 17,947,196 (excluding transaction fees such as stamp duty and transaction fees).

Gelonghui FinanceMar 4 06:50 ET

Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) Surges 4.5%; Private Companies Who Own 27% Shares Profited Along With Institutions

Key Insights Significant control over Micro-Tech (Nanjing)Ltd by private companies implies that the general public has more power to influence management and governance-related decisions 52% of the

Simply Wall StFeb 27 23:17 ET

Nanwei Medical (688029.SH)'s net profit in 2023 was 487 million yuan, up 47.31% year-on-year

Zhitong Finance App News, Nanwei Medical (688029.SH) released its 2023 annual performance report, achieving revenue of 2,416 billion yuan, an increase of 22.00% over the previous year. Net profit attributable to shareholders of listed companies was 487 million yuan, an increase of 47.31% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 464 million yuan, an increase of 54.86% over the previous year.

Zhitong FinanceFeb 22 05:08 ET

Does This Valuation Of Micro-Tech (Nanjing) Co.,Ltd (SHSE:688029) Imply Investors Are Overpaying?

Key Insights The projected fair value for Micro-Tech (Nanjing)Ltd is CN¥52.67 based on 2 Stage Free Cash Flow to Equity Micro-Tech (Nanjing)Ltd's CN¥69.98 share price signals that it might be 33% ov

Simply Wall StFeb 9 19:18 ET

Southern Weimedicine (688029.SH): Initial repurchase of 62,200 shares

Gelonghui, Feb. 7, 丨 Nanwei Medicine (688029.SH) announced that on February 7, 2024, 62,188 shares were repurchased for the first time through the Shanghai Stock Exchange trading system, accounting for 0.03% of the company's total share capital of 187,847,422 shares. The highest price of the repurchase transaction was 70.18 yuan/share, the lowest price was 67.91 yuan/share, and the total amount of capital paid was RMB 4,301,903.32 (excluding transaction fees such as stamp duty and transaction fees).

Gelonghui FinanceFeb 7 03:13 ET

Nanwei Medical (688029.SH): Plans to repurchase 20 million yuan to 40 million yuan of company shares

On February 4, Ge Longhui Medical (688029.SH) announced that the total amount of capital to be repurchased is not less than RMB 20 million, not more than RMB 40 million of the company's shares, and the repurchase price will not exceed RMB 122.90 per share.

Gelonghui FinanceFeb 4 04:32 ET

Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Stock Is Going Strong: Is the Market Following Fundamentals?

Micro-Tech (Nanjing)Ltd (SHSE:688029) has had a great run on the share market with its stock up by a significant 11% over the last three months. Given that the market rewards strong financials in th

Simply Wall StJan 19 20:38 ET

Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) Shareholders Might Be Looking For Exit

There wouldn't be many who think Micro-Tech (Nanjing) Co.,Ltd's (SHSE:688029) price-to-earnings (or "P/E") ratio of 37.1x is worth a mention when the median P/E in China is similar at about 35x. Howe

Simply Wall StDec 29, 2023 19:28 ET

Micro-Tech (Nanjing)Ltd (SHSE:688029) Might Be Having Difficulty Using Its Capital Effectively

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. One common approach is to try and find a company with return

Simply Wall StDec 11, 2023 17:48 ET